Clever Geek Handbook

Vaksin COVID-19 pertama. Perbandingan Sputnik V Rusia dan BNT162b2 Pfizer

Pada 9 November, raksasa farmasi Amerika - Pfizer mengumumkan keberhasilan penyelesaian uji klinis fase ketiga vaksin BNT162b2 melawan virus corona baru, dan hasil yang diperoleh 90% efektif.

Sangat mengherankan bahwa hanya 2 hari setelah siaran pers Pfizer, situs web vaksin Sputnik V Rusia (dinamai sesuai dengan prototipe kapal yang mengirim manusia pertama ke luar angkasa) menerbitkan pesan tentang efektivitas 92%.

Pada artikel ini, kita akan membandingkan kedua vaksin ini, menganalisis cara kerjanya, dan juga berbicara tentang mengapa komunitas ilmiah dunia cukup kritis terhadap vaksin Rusia.

Kandungan:

  1. Perbandingan hasil awal fase ketiga

  2. Bagaimana kekebalan terhadap virus muncul

  3. Jenis vaksin modern

  4. Cara kerja vaksin Sputnik V.

  5. Apa perbedaan antara vaksin dan Pfizer

  6. Hasil

Perbandingan hasil awal uji klinis fase ketiga

, - BNT162b2, Pfizer BioNTech, 43 , 90% .

, 94 COVID-19 , , 90% , . ā€” 7 . 38 . ā€” 14 , [1].

Sumber: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-vaccine-candidate-against
: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-vaccine-candidate-against

Ā« VĀ» 92% , COVID-19 16 21 , 20 [2].

Ā« VĀ» , 3- [3], , , 20 . , [4].

Sumber: https://sputnikvaccine.com/rus/newsroom/pressreleases/effektivnost-vaktsiny-sputnik-v-protiv-koronavirusa-sostavila-92-v-khode-pervogo-promezhutochnogo-an/
: https://sputnikvaccine.com/rus/newsroom/pressreleases/effektivnost-vaktsiny-sputnik-v-protiv-koronavirusa-sostavila-92-v-khode-pervogo-promezhutochnogo-an/

, . , , "" .

, ā€” ( ) [5].

, , , ā€” . , - ā€” , - .

: B- ( Bone marrow ā€” ) - ( Thymus ā€” ). , - , , ā€” - . - () - (-), ā€” , .

- -, , ā€” , - , , - , , , , .

ā€” , , .

:

, , . , , . :

  • ā€” , ā€” ā€” . , , MMR ā€” , . .

  • ā€” ā€” , , ā€” , , [6].

  • ā€” , . , , ā€” , , [7].

Ā« VĀ»

Ā«--Ā» Ā« VĀ» . , : ā€” -, , , , .

Ā« VĀ», . . . Sars-COV-2, (spike protein), .

: , , , - , -, [8].

Sumber: https://www.gamaleya.org/research/vaktsina-protiv-covid-19/
: https://www.gamaleya.org/research/vaktsina-protiv-covid-19/

Pfizer

BNT162b2 Pfizer BioNTech , ā€œā€ Ā« VĀ» .

BioNTech , , () , - [9].

BioNTech . Sars-COV-2 , Ā« VĀ» BNT162b2 ā€” .

BNT162b2 Ā« VĀ» , .

. Ā« VĀ» [3] [4].

:

, , , .

, , Ā« Ā», , .

1 https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-vaccine-candidate-against

2 https://sputnikvaccine.com/rus/newsroom/pressreleases/effektivnost-vaktsiny-sputnik-v-protiv-koronavirusa-sostavila-92-v-khode-pervogo-promezhutochnogo-an/

3 https://www.nature.com/articles/d41586-020-02386-2

4 https://www.nature.com/articles/d41586-020-03209-0

5 https://www.ncbi.nlm.nih.gov/books/NBK27140/#A449 6 https://www.niaid.nih.gov/research/vaccine-adjuvants

7 https://www.niaid.nih.gov/research/vaccine-types

8 https://www.gamaleya.org/research/vaktsina-protiv-covid-19/

9 https://biontech.de/covid-19



More articles:


All Articles